An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder

Objective: To assess efficacy and safety of mirabegron 25 mg/day and 50 mg/day for overactive bladder in Chinese participants. Methods: Participants of ≥18 years with overactive bladder symptoms lasting for ≥12 weeks, a mean of ≥8 micturitions per 24 h, and a mean of at least one episode of Grade 3...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Zhipeng Zhang, Deyi Luo, Zhong Chen, Peng Zhang, Ganping Zhong, Keji Xie, Zhuoqun Xu, Xudong Li, Jianye Wang, Yingfan Yang, Farid Abdul Hadi, Arianne Schild
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Elsevier 2025-01-01
श्रृंखला:	Asian Journal of Urology
विषय:	β3-adrenoceptor agonist Chinese population Micturition Mirabegron Overactive bladder
ऑनलाइन पहुंच:	http://www.sciencedirect.com/science/article/pii/S2214388224000936
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!